Jinyu Bio-Technology Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinyu Bio-Technology Co Ltd with three other
companies in this sector in China:
Beijing SL Pharmaceutical Co Ltd
sales of 1.01 billion Chinese Renmimbi [US$149.16 million]
of which 98%
was Pharmaceuticals Industry),
Staidson (Beijing) Biopharmaceuticals Co Ltd
(1.40 billion Chinese Renmimbi [US$207.28 million]
of which 100%
was Pharmaceutical manufacturing), and
Hualan Biological Engineering Inc
(1.93 billion Chinese Renmimbi [US$285.70 million]
of which 94%
was Blood Product).
During the year ended December of 2016, sales at
Jinyu Bio-Technology Co Ltd were 1.52 billion Chinese Renmimbi (US$224.08 million).
increase of 21.8%
versus 2015, when the company's sales were 1.25 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at Jinyu Bio-Technology Co Ltd.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
1,842.6% in 2016, from
1.96 million Chinese Renmimbi to 38.00 million Chinese Renmimbi.